Interpace Diagnostics Group, Inc.·4

Dec 6, 5:08 PM ET

Early James 4

4 · Interpace Diagnostics Group, Inc. · Filed Dec 6, 2018

Insider Transaction Report

Form 4
Period: 2018-12-05
Early James
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-12-05+15,00015,000 total
    Exercise: $1.08Exp: 2028-12-05Common Stock (15,000 underlying)
Holdings
  • Common Stock

    14,000
Footnotes (1)
  • [F1]The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT